Five Prime Therapeutics, Inc. Fair Value Assumptions, Expected Volatility Rate (Deprecated 2018-01-31)
Five Prime Therapeutics, Inc. reported Fair Value Assumptions, Expected Volatility Rate (Deprecated 2018-01-31) of 85.00% for the 3-month period ending 2014-03-31, per its 10-Q filed 2014-05-12.
Discontinued › Notes › Fair Value Measures and Disclosures
us-gaap:FairValueAssumptionsExpectedVolatilityRate · last filed 2015-03-18
- Five Prime Therapeutics, Inc. fair value assumptions, expected volatility rate (deprecated 2018-01-31) for the quarter ending 2014-03-31 was 85.00%.
- Five Prime Therapeutics, Inc. fair value assumptions, expected volatility rate (deprecated 2018-01-31) for fiscal 2012 was 85.00%, a 0.00% change from fiscal 2011.
- Five Prime Therapeutics, Inc. fair value assumptions, expected volatility rate (deprecated 2018-01-31) for fiscal 2011 was 85.00%.
| Period end | Fair Value Assumptions, Expected Volatility Rate (Deprecated 2018-01-31) 3 month | Fair Value Assumptions, Expected Volatility Rate (Deprecated 2018-01-31) 9 month | Fair Value Assumptions, Expected Volatility Rate (Deprecated 2018-01-31) 12 month |
|---|---|---|---|
| 2014-03-31 | 85.00% 10-Q · filed 2014-05-12 | ||
| 2013-09-30 | 85.00% 10-Q · filed 2013-11-13 | ||
| 2012-12-31 | 85.00% 10-K · filed 2015-03-18 | ||
| 2011-12-31 | 85.00% 10-K · filed 2014-03-26 |